Hepatitis Treatments

Latest Health Related News:
Cancer Prevention: The Upside To Allergies
A new article in the December issue of The Quarterly Review of Biology provides strong evidence that allergies are much more than just an annoying immune malfunction. They may protect against certain types of cancer.
MS Patients Have Significant And Sustained Reduction In Disability And Risk Of Relapse On Alemtuzumab Versus Approved Therapy, Rebif(R)
Genzyme Corporation (Nasdaq: GENZ) and Bayer HealthCare Pharmaceuticals Inc. today announced study results showing that patients with early relapsing-remitting multiple sclerosis (RRMS) taking once-yearly cycles of alemtuzumab reduced their risk of relapse by 74 percent and the risk of sustained accumulation of disability by 71 percent compared to patients treated with the active comparator Rebif® (high-dose interferon beta-1a).
Release by ENT Doctors of National Guideline On Treatment For Common Cause Of Dizziness
The American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) will issue a comprehensive clinical guideline to help healthcare practitioners identify and treat patients with benign paroxysmal positional vertigo (BPPV), one of the most common underlying conditions that cause dizziness. The guideline emphasizes evidence-based recommendations on managing BPPV, the most common vestibular (inner ear) disorder in adults.